Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review

被引:17
|
作者
Marin, Mona [1 ]
Leung, Jessica [1 ]
Gershon, Anne A. [2 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pediat, New York, NY USA
关键词
SAFETY PROFILE; UNITED-STATES; CHILDREN; LEUKEMIA; IMMUNIZATION; PROGRAM; PREVENTION; EFFICACY; IMPACT; TRIAL;
D O I
10.1542/peds.2019-1305
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We reviewed the published experience with the use of live VZV vaccines to assess characteristics of secondary transmission of the vaccine-strain virus. CONTEXT:Live vaccines usually provide robust immunity but can transmit the vaccine virus.OBJECTIVE:To assess the characteristics of secondary transmission of the vaccine-strain varicella-zoster virus (Oka strain; vOka) on the basis of the published experience with use of live varicella and zoster vaccines.DATA SOURCES:Systematic review of Medline, Embase, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, and Scopus databases for articles published through 2018.STUDY SELECTION:Articles that reported original data on vOka transmission from persons who received vaccines containing the live attenuated varicella-zoster virus.DATA EXTRACTION:We abstracted data to describe vOka transmission by index patient's immune status, type (varicella or herpes zoster) and severity of illness, and whether transmission was laboratory confirmed.RESULTS:Twenty articles were included. We identified 13 patients with vOka varicella after transmission from 11 immunocompetent varicella vaccine recipients. In all instances, the vaccine recipient had a rash: 6 varicella-like and 5 herpes zoster. Transmission occurred mostly to household contacts. One additional case was not considered direct transmission from a vaccine recipient, but the mechanism was uncertain. Transmission from vaccinated immunocompromised children also occurred only if the vaccine recipient developed a rash postvaccination. Secondary cases of varicella caused by vOka were mild.LIMITATIONS:It is likely that other vOka transmission cases remain unpublished.CONCLUSIONS:Healthy, vaccinated persons have minimal risk for transmitting vOka to contacts and only if a rash is present. Our findings support the existing recommendations for routine varicella vaccination and the guidance that persons with vaccine-related rash avoid contact with susceptible persons at high risk for severe varicella complications.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit
    Molyneaux, PJ
    Parker, S
    Khan, IH
    Millar, CGM
    Breuer, J
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (01) : 76 - 78
  • [42] Varicella-zoster vaccine for the prevention of herpes zoster
    Kimberlin, David W.
    Whitley, Richard J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13): : 1338 - 1343
  • [43] SAFETY AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS (VZV) VACCINE IN ADULTS
    KUMAR, ML
    COLLINS, MS
    GOPALAKRISHNA, KV
    PEDIATRIC RESEARCH, 1986, 20 (04) : A313 - A313
  • [44] ANTIGENICITY OF A CANDIDATE VARICELLA-ZOSTER VIRUS GLYCOPROTEIN SUBUNIT VACCINE
    VAFAI, A
    VACCINE, 1993, 11 (09) : 937 - 940
  • [45] SUSCEPTIBILITY OF VACCINE STRAINS OF VARICELLA-ZOSTER VIRUS TO ANTIVIRAL COMPOUNDS
    PREBLUD, SR
    ARBETER, AM
    PROCTOR, EA
    STARR, SE
    PLOTKIN, SA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) : 417 - 421
  • [46] Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine
    Levin, Myron J.
    Cai, Guang-Yun
    Lee, Katherine S.
    Rouphael, Nadine G.
    Mehta, Aneesh K.
    Canniff, Jennifer
    Mulligan, Mark J.
    Weinberg, Adriana
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (07): : 1055 - 1059
  • [47] Lineages of varicella-zoster virus
    McGeoch, Duncan J.
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 963 - 969
  • [48] VARICELLA-ZOSTER VIRUS PNEUMONITIS
    FELDMAN, S
    CHEST, 1994, 106 (01) : S22 - S27
  • [49] LIPOPROTEINS OF VARICELLA-ZOSTER VIRUS
    HARPER, DR
    KANGRO, HO
    JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 459 - 463
  • [50] Varicella-zoster virus inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (03) : 123 - 123